Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-16

Clinical Trial Update: Spironolactone in Patients With Single Ventricle Heart [NA]

View source ↗

Summary

Clinical trial update on spironolactone in patients with single-ventricle congenital heart disease; the study has completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: Emory University | Conditions: Congenital Disorders | NA | Status: COMPLETED | Results posted: 2014-12-16